Cargando…
Predicting Chronic Subdural Hematoma Recurrence and Stroke Outcomes While Withholding Antiplatelet and Anticoagulant Agents
Introduction: The aging of the western population and the increased use of oral anticoagulation (OAC) and antiplatelet drugs (APD) will result in a clinical dilemma on how to balance the recurrence risk of chronic subdural hematoma (cSDH) with the risk of withholding blood thinners. Objective: To id...
Autores principales: | Zanaty, Mario, Park, Brian J., Seaman, Scott C., Cliffton, William E., Woodiwiss, Timothy, Piscopo, Anthony, Howard, Matthew A., Abode-Iyamah, Kingsley |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6974672/ https://www.ncbi.nlm.nih.gov/pubmed/32010052 http://dx.doi.org/10.3389/fneur.2019.01401 |
Ejemplares similares
-
Antiplatelet/Anticoagulant Agents and Chronic Subdural Hematoma in the Elderly
por: De Bonis, Pasquale, et al.
Publicado: (2013) -
Recurrent Subdural Hematoma: An Institutional Experience
por: Swamiyappan, Sai Sriram, et al.
Publicado: (2023) -
Symmetrical Interhemispheric Subdural Hematoma
por: Uchio, Naohiro, et al.
Publicado: (2021) -
Neurogenic Dysphagia in Subdural Hematoma
por: Won, Sae-Yeon, et al.
Publicado: (2022) -
Influence of Antiplatelet and Anticoagulant Drug Use on Outcomes after Chronic Subdural Hematoma Drainage
por: Poon, Michael T.C., et al.
Publicado: (2021)